Dr Harry Smith

Dr. Harry Smith has a vast and diverse work experience history. Dr Harry started their career as a Specialist Registrar in Anaesthetics at NHS Trust in 2001. Dr Harry then transitioned into the pharmaceutical industry, holding roles as a Medical Advisor at sanofi-aventis, Medical Manager at Pfizer responsible for Europe and Canada, and later as the European Head of Medical Affairs - Pain at Mundipharma International Limited. Dr. Smith further developed their career at Mallinckrodt Pharmaceuticals, where they served as Senior Director and Executive Director in various strategic and innovative positions. Currently, they hold the position of Global Head of Medical Affairs at Grünenthal Group. Overall, Dr. Smith's experience spans across medical affairs, strategy, and business development in the pharmaceutical industry.

Dr. Harry Smith obtained a Diploma in Advanced Studies in Pharmaceutical Medicine from the University of Basel in 2011. Prior to that, they earned their MD - Bachelor of Medicine & Surgery (MBBCh) from the University of the Witwatersrand and a Diploma in Anaesthetics from the South African College of Medicine. Additionally, they attended King's College London, though specific details regarding their degree and field of study are not provided.